Zeynep Kamil Kadın ve Çocuk Hastalıkları Eğitim ve Araştırma Hastanesi
Üsküdar, Istanbul, 34000, Turkey (Türkiye)
NCT Number: NCT07097766
This study aims to evaluate the effect of an educational intervention based on the Health Belief Model (HBM) combined with motivational interviewing on women's knowledge about Human Papillomavirus (HPV) infection and their awareness of HPV vaccination. The study will be conducted among women aged 18-45 who have not received the HPV vaccine. Participants in the intervention group will receive structured education and motivational interviews, while the control group will receive no intervention. Changes in HPV knowledge and vaccine awareness will be measured before and after the intervention using validated scales. The goal is to improve preventive behaviors and increase vaccine uptake through behavior-based education.
Trial opening soon.
Get Notified18 year–45 year
Female
Interventional
Not applicable
Üsküdar, Istanbul, 34000, Turkey (Türkiye)
This randomized controlled trial is designed to assess the impact of education and motivational interviewing grounded in the Health Belief Model (HBM) on women's knowledge regarding HPV and awareness of the HPV vaccine. The study population consists of 18-45-year-old literate women who have not previously received HPV vaccination.
Participants will be randomly assigned to either an intervention group or a control group. The intervention group will receive a 3-session structured education program based on HBM constructs (perceived susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy), supported by motivational interviewing techniques. The control group will receive no intervention.
Data collection will include pre- and post-intervention assessments using a validated HPV knowledge scale and vaccine awareness questionnaire. The expected outcome is a statistically significant improvement in knowledge and awareness in the intervention group.
This study aims to contribute to public health efforts in HPV prevention and vaccination promotion by utilizing a behavioral model in community education.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Voluntary participation and providing informed consent
Not previously vaccinated against HPV
Ability to attend all three educational and motivational interview sessions
Literacy sufficient to complete study questionnaires
Exclusion criteria
Prior HPV vaccination
Cognitive or psychiatric conditions that hinder participation
Currently participating in another HPV-related education or intervention study
Inability to attend all sessions of the intervention program
This intervention consists of a structured 3-session educational program and motivational interviews based on the Health Belief Model (HBM). It aims to increase knowledge about HPV infection and improve HPV vaccination awareness among women aged 18-45.
Time frame: 4 weeks after the intervention
Participants' total score on an HPV knowledge questionnaire designed to assess understanding of HPV infection, transmission, and prevention.
Time frame: 4 weeks after the intervention
Participants' awareness level regarding HPV vaccination, measured using a structured 10-item survey.
Contact information is provided by the study sponsor or research team.
Saglik Bilimleri Universitesi
Other
The Effect of Health Belief Model-Based Education and Motivational Interviewing on Human Papillomavirus (HPV) Infection Knowledge Level and HPV Vaccine Awareness Among Women
Acronym: HPV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07036211
Cervical Carcinoma, Communicable Diseases
Kuopio, Finland
View Trial DetailsNCT06557954
Cancer Screening, Cervical Cancer
Beijing, Beijing Municipality, China
View Trial DetailsNCT05057312
Communicable Diseases, DNA Virus Infections
Houston, Texas, United States
View Trial DetailsNCT07521163
Adherence Interventions, Behavior
Van, Turkey (Türkiye)
View Trial Details